Deep clefts are a cause of early failure of mitral valve repair, but it is not known whether clefts represent normal morphology, or whether they occur more frequently in mitral valve prolapse (MVP).
Introduction
Mitral regurgitation (MR) is the most frequent valvular lesion in the western world, 1 and mitral valve prolapse (MVP) the second most frequent valve lesion requiring surgery. 2 Cardiologists focus on the severity of MR and the timing of surgical intervention, but our description of the abnormality is usually limited to localizing the region of the valve affected and the mechanism of failure. Real-time three-dimensional trans-oesophageal echocardiography (TOE) has revolutionized our ability to assess the mitral valve in vivo; moreover, cardiologists can now not only appreciate the visual appearance of prolapsing mitral valves as cardiothoracic surgeons have for years, but we can assess the physiological implications of the abnormalities seen.
One feature of MVP is the appearance of deep clefts in the mitral leaflets. Clefts have been referred to in the literature previously as 'slits' or 'interscallops malcoaptation', 3 -5 and are a risk factor for early failure of mitral repair. 5 However, there has been no attempt to clarify the pre-surgical impact of clefts, nor is it clear whether clefts are a normal morphological finding, or whether they are more common in patients with MVP. Accordingly, the aims of this study were: to determine the accuracy of 3D-TOE in diagnosing the presence of clefts; to document the occurrence and distribution of clefts in patients with and without MVP; and to describe the impact of clefts on MR.
Methods

Defining clefts
Similar to a previous definition, 3 we defined a deep cleft at surgery as a narrow gap that extends at least one half of the way from the free edge toward the hingeline (annulus). They have chordal attachments separating them from neighbouring sections of the valve. On echocardiography, we defined a cleft as a visible defect that can be seen during systole and diastole, similarly extending at least one half of the depth of the adjacent mitral leaflet ( Figure 1A -H ).
Patient population
We included consecutive patients undergoing TOE for the assessment of MR between September 2009 and January 2011. TOE findings were recorded prospectively. We divided patients into those with MVP or flail, and those with an alternative mechanism of MR. Mitral valve prolapse was defined as the displacement of the tip of one or more segments of the mitral valve by ≥2 mm relative to the hingepoints of the leaflets, and flail was defined as the systolic eversion of the tip of the leaflet into the left atrium. A subset of patients underwent mitral valve repair subsequent to TOE in our imaging service; in these patients, we compared 3D TOE results with observations of the valve made under direct inspection during surgery. We chose this method as it allows us to validate what we see on 3D TOE images, and then to expand the study cohort to allow us to make observations regarding the occurrence of slits on a larger group of patients using 3D TOE alone. In the 'alternative MR' group, we included patients with functional MR (defined as MR secondary to global or regional left ventricular dysfunction with restricted leaflet motion) and pure annular dilatation (defined as MR secondary to loss of coaptation with normal leaflet motion). These definitions were made according to Carpentier's description. 6 To determine the frequency of clefts in a normal population, we included consecutive patients undergoing TOE with less than mild MR, no evidence of mitral stenosis or prolapse, normal LV size and function without regional wall motion abnormalities, and no significant aortic valve disease. Institutional approval was granted for the study.
Image acquisition
Images were acquired using X72t transducers and an iE33 imaging platform (Philips, Andover, MA, USA). Images were analyzed online or offline using Xcelera. Echocardiographic studies were performed in keeping with guidance from the European Association of Echocardiography. 7 The severity of MR was classified into mild, moderate, moderate to severe, or severe, using a multiparametric approach as advised by recent guidelines, 7 including an assessment of the effective regurgitant orifice area as determined by the PISA method, in addition to the jet area, regurgitant volume, and vena contracta. Transoesophageal echocardiography studies were performed under anaesthetic or conscious sedation, paying particular attention to ensure that systolic blood pressure was maintained throughout the examination. Two echo experts, blinded to each others' findings, recorded a detailed description of each valve using a combination of 2D and 3D imaging. We systematically assessed the mitral valve, documenting the presence of prolapse or flail and the region affected according to
Carpentier's nomenclature. 8 Three-dimensional TOE images were acquired from the mid-oesophagus using the 3D zoom or live 3D function. Care was taken with the depth and gain settings, and sector width was adjusted such that we included the leaflets and annulus in their entirety throughout the cardiac cycle, ensuring frame rates of at least 7 Hz. We recorded the number and distribution of clefts in each patient, starting from the antero-lateral commissure and working across the valve toward the postero-medial commissure.
The association of the clefts with the prolapsing or flail region of the valve was documented.
We classified further the type of lesion seen in the patients with MVP, according to previous descriptions. Those individuals with thickened, myxomatous leaflets, leaflet billowing and multisegment prolapse we labelled 'Barlow's disease', 9,10 and those individuals with an isolated segment of prolapse or flail with leaflet thinning were labelled fibro-elastic deficiency. 10, 11 If the pattern of prolapse did not fit easily into either category, we labelled the patient as 'indeterminate'. 12 We were then able to describe the number of clefts according to the pattern of disease.
To assess the impact of clefts on MR severity and complexity, we used a combination of techniques. Using 2D TOE with Doppler colour mapping, we carefully assessed the valve, in particular looking for areas of regurgitation originating away from the line of coaptation. 
Surgical assessment
For the surgical cohort, operative techniques and findings were recorded prospectively. After midline sternotomy and institution of cardiopulmonary bypass, the cavae were snared, and the left atrium opened posterior to Sondegaard's groove. After insufflation of the ventricle, the mitral valve was inspected. The surgeon recorded the number, distribution, and depth of any clefts, along with the region of prolapse. The surgeon then proceeded with repair of the valve.
Statistical analysis
All statistical analysis was performed using Graphpad v 5.0 (GraphPad Software Inc., CA, USA). We assessed the sensitivity and specificity of TOE in visualizing clefts when compared with direct inspection of the valve made during surgery. Fisher's exact test was used to compare the frequency of clefts in MVP vs. the alternative MR group and control patients. ANOVA with post test Bonferroni correction was used to compare characteristics between groups. P-values of ,0.05 were considered statistically significant.
Results
Baseline characteristics are in Table 1 . We included 76 patients with MVP, 57 control patients, and 43 patients with alternative MR, which included: pure annular dilatation (n ¼ 24) and functional MR (n ¼ 19).
Three-dimensional echocardiographic findings
The surgical corroboration group consisted of 50 patients. This included 38 patients from the MVP group and 12 individuals with alternative causes of MR. The type of valve lesions in these 50 patients were: Barlow's disease (n ¼ 14); fibro-elastic deficiency (n ¼ 15); indeterminate MVP lesion (n ¼ 9); pure annular dilatation (n ¼ 7); and functional MR (n ¼ 5). When compared with direct inspection of the valve, 3D TOE was 93% sensitive and 92% specific for the detection of clefts. There were four false positives in the 3D TOE group (5%): in all of these patients, a prominent 'fold' was misinterpreted as a cleft.
Reviewing the MVP cohort as a whole, 64 of the 76 patients (84%) had clefts, the mean number of clefts was 2.1 per patient, and 30 patients (39%) had three or more clefts visualized ( Table 2 the posterior leaflet in all 64 patients. We only saw clefts on the anterior mitral leaflet in six patients: five of these had bileaflet prolapse, and the remaining one had A3 and P3 prolapse. In the alternative MR cohort, we only saw clefts in seven patients (16%). This was significantly less frequent than in the MVP cohort (16 vs. 84%; P , 0.001).
We subdivided the patients with MVP into 'Barlows disease', 'fibro-elastic deficiency', or 'indeterminate' reflecting the spectrum of disease in MVP. When we compare the number of clefts seen to the type of MVP lesion, we see a step-wise increase in the mean number of clefts seen as the prolapse becomes more extensive (Graph 1: fibroelastic deficiency 1.8 + 0.5; Barlow's disease 3.7 + 1.1; indeterminate 2.5 + 0.8; P , 0.01 between groups).
The location of clefts was equally important in determining the lesion in MVP. The most common pattern was an isolated flail or prolapsing segment with clefts either side. When the clefts were close together, this resulted in a limited prolapsing region, but as the clefts became further apart, so the region of prolapse increased ( Figure 3) . With extensive prolapse, clefts were visualized along the prolapsing leaflet (Figures 1 and 2) . 
Two-dimensional echo comment
We could not directly visualize clefts using 2D imaging, but there were some 2D echocardiographic characteristics that provided clues as to their presence. Figure 4A demonstrates the typical appearance of a patient with clefts in the bicommissural view: note the 'folds' seen with chordal attachments at the nadir of each fold. When looking at the valve under direct inspection, the chordal attachments can be seen around each cleft ( Figure 4B) . Conversely, when we see a patient with bileaflet prolapse and severe MR but without clefts, note how the leaflets are smooth and featureless ( Figure 4C and D) .
Impact on regurgitant flow
Forty-two patients were seen to have regurgitation through a cleft in addition to the regurgitation through the region of prolapse. Thirteen patients had flow through more than one cleft. Threedimensional echo enabled us to visualize regurgitation through more than one cleft on all 13 occasions, whereas 2D imaging could only identify one such patient. Two-dimensional imaging was superior in patients with AF where full-volume 3D images were affected by 'stitching artefact'. 
Control patients
Fifty-seven control patients undergoing TOE were included. The diagnoses of these patients were: PFO (n ¼ 26) small secundum ASD (n ¼ 13) normal AF (n ¼ 4) pulmonary AVM (n ¼ 2) and mild pulmonary stenosis (n ¼1). Seven patients had clefts (12%, Figure 5 ), which were similar to the prevalence in patients with alternative MR, but significantly less frequent than in the cohort with MVP (12 vs. 84%; P , 0.001).
Impact on surgical repair
In the surgical corroboration group, one patient with extensive bileaflet prolapse required mitral valve replacement. The remaining patients all had a successful valve-sparing procedure, irrespective of whether clefts were present or not. Four patients had mild residual MR, and the remainder had trivial or no residual MR post-surgery. No patients required a second pump run.
Discussion
Using 3D TOE and surgical corroboration, we have categorized the appearance, frequency, and clinical impact of clefts in the mitral valve leaflets. Recent work demonstrated the ability of 3D TOE to examine the mitral valve in exquisite detail in vivo, and this modality approaches direct visualization in its ability to identify morphological abnormalities of the leaflets. There has been no previous attempt to compare the prevalence of clefts in patients with and without MVP, nor to document their impact on MR prior to surgical repair.
Normal morphology
There is a lack of consistent nomenclature with regards clefts in the mitral valve. Ranganathan et al. 13 first described indentations in the posterior leaflet that divided it into scallops, most frequently 3. These indentations were subsequently used to facilitate segmental analysis of the valve. 8, 14 Victor and Nayak 15 later reported that 98% of normal posterior mitral leaflets had clefts with associated 'pleats'. Conversely, none of the valves studied had clefts in the anterior leaflet. Most control patients in our study had intact leaflets. However, in five patients, a deep cleft could be seen ( Figure 5A-C ) . Deep clefts as defined in our study are therefore part of the spectrum of normality, which is in contrast to earlier work, suggesting that clefts are a rare occurrence, 16 or most frequently associated with congenital heart disease.
17,18
Mitral valve prolapse morphology
When we examine patients with MVP, it is clear that deep clefts occur significantly more frequently than in normal controls. It is this that leads us to believe that clefts may play an important role in the mechanism of MVP. Other observations support this assertion. Clefts are always associated with the region of abnormality, most frequently around a focal prolapse or flail segment. As the extent of the prolapse increases, so does the number of clefts visualized. The counter argument is that deep clefts are a consequence of the disease process: as the leaflets prolapse the 'normal' inter-segmental region becomes more prominent. We do not concur with this view: if it were true, we would expect clefts to be a universal finding in prolapsing valves, yet in 16% of our patients with MVP no clefts were seen. Additionally, in our MVP cohort, we purposefully included patients with mild MR. Clefts were equally prominent as in those patients with more advanced disease, suggesting that the appearance of clefts precedes or at least runs parallel with the development of MVP. Finally, the frequency of deep clefts in the 'alternative MR' cohort was similar to normal controls, supporting the perspective that these deep clefts are important in MVP, and are not simply a feature of valvular insufficiency per se.
The mitral valve faces a unique haemodynamic challenge. It tolerates an enormous degree of physiological stress during the lifetime of an individual; to achieve this requires the delicate and coordinated function of its anatomical components. 19 Even the 'saddle- 24 A subset of patients in our MVP cohort had typical Barlow's disease, and some patients had lesions consistent with fibro-elastic degeneration. Clefts were documented in patients across the whole spectrum of MVP, which may be consistent with a common origin of the disease. We wonder whether the number, distribution, and depth of clefts are important determinants here: with multiple deep clefts the patients presented with multi-segment prolapse. Conversely, the patients with one or two deep clefts were seen to have a limited flail or prolapsing segment. Additionally, this work demonstrates that the traditional division of the posterior leaflet into three segments is a simplification, as a significant proportion of our MVP cohort did not conform to this morphological phenotype. This is consistent with the early descriptions of the mitral valve, 13, 15 and more recent work using endoscopic visualization of human mitral valve specimens. 25 In itself, this has implications when considering patients for mitral valve repair, and may alter the surgical approach to such a patient.
Impact on regurgitation
We demonstrated that clefts impact upon the regurgitant burden and complexity of the regurgitant jet in MVP. Determining the severity of MR using 2D echo is well established, 7 but these techniques may be inadequate in the assessment of regurgitation occurring through clefts owing to the eccentric origin of the jet and unusual shape of the regurgitant orifice. 26, 27 There is work using 3D colour imaging to measure the regurgitant orifice directly, 28 but this technique has not been widely accepted. Given these difficulties, we simply assessed whether or not regurgitation was occurring through the clefts.
Conclusions
Deep clefts are morphological abnormalities of the mitral leaflets that are a frequent finding in MVP. They occur rarely in normal controls or patients with alternative causes of MR. Clefts always appear in prolapsing regions or framing them, and occur in increasing numbers in line with the proportion of the valve that is prolapsing. They consequently may have an important role in the mechanism of MVP. Evaluation of the morbid anatomy of leaking mitral valves is best achieved using 3D TOE, which allows us to document the occurrence, distribution, extent, and clinical impact of clefts.
Limitations
This article is hypothesis generating and ideally longitudinal studies would be required to document changes in the mitral leaflet in patients with clefts. It is a single centre study with small numbers of patients and needs to be validated on a larger scale. The surgeon was not blinded to the results of the 3D TOE at the time of surgery. Live 3D TOE imaging has excellent spatial resolution at the expense of temporal resolution. Interpretation of the echocardiographic images may be affected by low frame rates.
